Eli A. Friedman

12.5k total citations · 3 hit papers
292 papers, 8.9k citations indexed

About

Eli A. Friedman is a scholar working on Nephrology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eli A. Friedman has authored 292 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Nephrology, 52 papers in Surgery and 41 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eli A. Friedman's work include Dialysis and Renal Disease Management (76 papers), Renal Transplantation Outcomes and Treatments (30 papers) and Organ Donation and Transplantation (25 papers). Eli A. Friedman is often cited by papers focused on Dialysis and Renal Disease Management (76 papers), Renal Transplantation Outcomes and Treatments (30 papers) and Organ Donation and Transplantation (25 papers). Eli A. Friedman collaborates with scholars based in United States, Canada and Taiwan. Eli A. Friedman's co-authors include T. K. Sreepada Rao, Onyekachi Ifudu, Anthony D. Nicastri, Amgad N. Makaryus, Barbara G. Delano, Vera Delaney, Zenji Makita, Anthony Cerami, John P. Merrill and Edward Y. Skolnik and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Eli A. Friedman

278 papers receiving 8.2k citations

Hit Papers

Advanced Glycosylation En... 1984 2026 1998 2012 1991 1989 1984 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Eli A. Friedman 3.0k 1.3k 1.2k 1.1k 1.1k 292 8.9k
Walter H. Hörl 4.2k 1.4× 2.4k 1.7× 2.5k 2.0× 2.2k 2.0× 980 0.9× 393 13.4k
Sydney Tang 4.3k 1.4× 1.1k 0.8× 641 0.5× 2.0k 1.9× 676 0.6× 314 9.4k
Kar Neng Lai 5.9k 2.0× 1.4k 1.0× 1.1k 0.9× 2.2k 2.1× 543 0.5× 354 12.9k
Michel Jadoul 4.5k 1.5× 1.4k 1.0× 452 0.4× 1.1k 1.0× 678 0.6× 270 11.5k
Shin‐Wook Kang 6.1k 2.1× 1.7k 1.2× 733 0.6× 2.2k 2.0× 1.3k 1.2× 530 12.4k
Robert H. Mak 3.4k 1.2× 1.1k 0.8× 501 0.4× 963 0.9× 743 0.7× 155 7.9k
Richard J. Glassock 7.9k 2.7× 1.2k 0.9× 715 0.6× 2.0k 1.9× 901 0.9× 261 12.8k
Jeffrey C. Fink 2.1k 0.7× 1.6k 1.2× 554 0.4× 358 0.3× 907 0.9× 175 8.3k
Roberto Pecoits‐Filho 7.0k 2.4× 2.3k 1.7× 1.3k 1.0× 1.1k 1.0× 1.3k 1.3× 383 13.2k
Chul Woo Yang 3.0k 1.0× 2.2k 1.7× 646 0.5× 2.0k 1.9× 597 0.6× 526 9.8k

Countries citing papers authored by Eli A. Friedman

Since Specialization
Citations

This map shows the geographic impact of Eli A. Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli A. Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli A. Friedman more than expected).

Fields of papers citing papers by Eli A. Friedman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eli A. Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli A. Friedman. The network helps show where Eli A. Friedman may publish in the future.

Co-authorship network of co-authors of Eli A. Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of Eli A. Friedman. A scholar is included among the top collaborators of Eli A. Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eli A. Friedman. Eli A. Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Friedman, Eli A.. (2010). Stressful ethical issues in uremia therapy: Long Island College Hospital Conference, 30 May 2008, Brooklyn, New York, USA. Kidney International. 78(117). S22–S32. 6 indexed citations
3.
Friedman, Eli A., Francis A. L'Espérance, Clinton D. Brown, & David H. Berman. (2003). Treating azotemia-induced anemia with erythropoietin improves diabetic eye disease. Kidney International. 64(87). S57–S63. 35 indexed citations
4.
Friedman, Eli A. & Francis A. L'Espérance. (2002). Diabetic renal-retinal syndrome : pathogenesis and management update 2002. Kluwer Academic eBooks. 1 indexed citations
5.
Ifudu, Onyekachi, et al.. (2002). Relation between Interdialytic Weight Gain, Body Weight and Nutrition in Hemodialysis Patients. American Journal of Nephrology. 22(4). 363–368. 36 indexed citations
6.
Friedman, Eli A. & Francis A. L'Espérance. (1998). Diabetic renal-retinal syndrome : 21st century management now. Kluwer Academic Publishers eBooks. 3 indexed citations
7.
Miles, Anne Marie V., Mariana Markell, P. Daskalakis, et al.. (1997). Anemia following renal transplantation: erythropoietin response and iron deficiency. Clinical Transplantation. 11(4). 313–315. 50 indexed citations
8.
Brown, Chris, et al.. (1995). Erythropoietin delays the onset of uremia in anemic azotemic diabetic predialysis patients. Journal of the American Society of Nephrology. 6(3). 447. 5 indexed citations
9.
Friedman, Eli A.. (1994). The Best and Worst Times for Dialytic Therapy Are Now. ASAIO Journal. 40(2). 107–108. 1 indexed citations
10.
Sumrani, Nabil, Veronica Delaney, Robert P. Davis, et al.. (1991). Posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients.. PubMed. 23(1 Pt 2). 1249–50. 28 indexed citations
11.
Friedman, Eli A., et al.. (1989). AIDS (HIV)-Associated Nephropathy; Does It Exist?. American Journal of Nephrology. 9(6). 441–453. 17 indexed citations
12.
Friedman, Eli A.. (1987). Medicaid's overload sparks a crisis.. PubMed. 61(2). 50–4. 3 indexed citations
13.
Lundin, Peter, Richard A. Stein, Clinton D. Brown, et al.. (1987). Fatigue, Acid-Base and Electrolyte Changes with Exhaustive Treadmill Exercise in Hemodialysis Patients. ˜The œNephron journals/Nephron journals. 46(1). 57–62. 16 indexed citations
14.
Friedman, Eli A.. (1984). The big question: who joins HMOs?. PubMed. 58(8). 102–3. 1 indexed citations
15.
Friedman, Eli A., et al.. (1981). Measurement of serum ionized magnesium in acute respiratory alkalosis and acidosis in the dog. Kidney International. 19(1). 109. 4 indexed citations
16.
Friedman, Eli A., et al.. (1978). Chronic familial hyperphosphatasemia. [/sup 99m/Tc-dipphosphonate]. Radiology. 1 indexed citations
17.
Rao, T. K. Sreepada, Thomas Manis, Barbara G. Delano, et al.. (1978). Relationship of plasma lipids to renal function and length of time on maintenance hemodialysis. American Journal of Clinical Nutrition. 31(10). 1886–1892. 23 indexed citations
18.
Friedman, Eli A., et al.. (1978). Reduction in hyperlipidemia in hemodialysis patients treated with charcoal and oxidized starch (oxystarch). American Journal of Clinical Nutrition. 31(10). 1903–1914. 4 indexed citations
19.
Rao, T. K. Sreepada, Thomas Manis, Barbara G. Delano, & Eli A. Friedman. (1973). CONTINUING HIGH MORBIDITY DURING MAINTENANCE HEMODIALYSIS CONSEQUENT TO BILATERAL NEPHRECTOMY. ASAIO Journal. 19(1). 340–344. 6 indexed citations
20.
Goodwin, Norma J., Carlo Valenti, J. Edward Hall, & Eli A. Friedman. (1968). Effects of uremia and chronic hemodialysis on the reproductive cycle. American Journal of Obstetrics and Gynecology. 100(4). 528–535. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026